Non-Hodgkin's lymphomas.

[1]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[2]  N. Harris,et al.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. , 2008, Blood.

[3]  M. Calaminici,et al.  Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Ng,et al.  Role of radiation therapy in localized aggressive lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Sigrid Stroobants,et al.  Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Weisenburger,et al.  Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Clinicopathologic Study of 340 Cases from the International T-Cell Lymphoma Project. , 2006 .

[7]  P. Solal-Céligny.  Follicular lymphoma international prognostic index , 2006, Current treatment options in oncology.

[8]  J. Yahalom,et al.  Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT). , 2005, International journal of radiation oncology, biology, physics.

[9]  E. Furhang,et al.  Radiation treatment planning techniques for lymphoma of the stomach. , 2005, International journal of radiation oncology, biology, physics.

[10]  C. Dunphy,et al.  Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. , 2004, Archives of pathology & laboratory medicine.

[11]  T. Miller.  The limits of limited stage lymphoma. , 2004, Journal of Clinical Oncology.

[12]  J. Earle,et al.  Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Avilés,et al.  Retracted: Adjuvant Radiotherapy in Stage IV Diffuse Large Cell Lymphoma Improve Outcome , 2004, Leukemia & lymphoma.

[14]  M. Paulli,et al.  Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B , 2004, British Journal of Cancer.

[15]  R. Gascoyne,et al.  Limited-stage mantle-cell lymphoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  A. Hart,et al.  High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Haas,et al.  HOVON 47/EORTC 20013: chlorambucil vs 2×2 Gy involved field radiotherapy in stage III/IV previously untreated follicular lymphoma patients , 2003, Annals of Hematology.

[18]  A. Avilés,et al.  Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy , 2002, Annals of Hematology.

[19]  A. Ng,et al.  Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. , 2002, International journal of radiation oncology, biology, physics.

[20]  S. Tucker,et al.  Long-term results with radiotherapy for Stage I-II follicular lymphomas. , 2001, International journal of radiation oncology, biology, physics.

[21]  J. Yahalom.  MALT Lymphomas: A radiation oncology viewpoint , 2001, Annals of Hematology.

[22]  S. Koscielny,et al.  A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. , 2001, International journal of radiation oncology, biology, physics.

[23]  A. Bezjak,et al.  Stage I and II MALT lymphoma: results of treatment with radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[24]  S. Tucker,et al.  Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. , 2000, International journal of radiation oncology, biology, physics.

[25]  G. Ceresoli,et al.  Consolidation Radiotherapy to Bulky or Semibulky Lesions in the Management of Stage III–IV Diffuse Large B Cell Lymphomas , 2000, Oncology.

[26]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Weisenburger,et al.  New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Labopin,et al.  Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Fisher,et al.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.

[30]  J. Yahalom,et al.  Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. M. Mac Manus,et al.  Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Avilés,et al.  Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. , 1994, International journal of radiation oncology, biology, physics.

[33]  K. Maclennan,et al.  Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. , 1994, British Journal of Cancer.

[34]  M. Shipp.  Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? , 1994, Blood.

[35]  D. Longo.  Combined modality therapy for localized aggressive lymphoma: enough or too much? , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  M. Shipp,et al.  Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  M. Gospodarowicz,et al.  Role of radiation therapy in localized non-Hodgkin's lymphoma. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  M. Gospodarowicz,et al.  Radiation therapy of localized non-Hodgkin's lymphoma. , 1977, Cancer treatment reports.

[39]  R. Fisher,et al.  Diffuse aggressive lymphoma. , 2004, Hematology. American Society of Hematology. Education Program.

[40]  F. Cavalli,et al.  Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. , 2002, Haematologica.

[41]  A. Bezjak,et al.  Primary gastric lymphoma: brief overview of the recent Princess Margaret Hospital experience. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[42]  N. Harris,et al.  Mucosa‐associated lymphoid tissue lymphoma of the stomach , 1999, Cancer.